Chemical Formula: C22H31NO2

Chemical Formula C22H31NO2

Found 54 metabolite its formula value is C22H31NO2

LINDHEIMERINE

LINDHEIMERINE

C22H31NO2 (341.2355)


   

Pregnenolone carbonitrile

Pregnenolone carbonitrile; 3beta-Hydroxy-20-oxo-5-pregnene-16alpha-carbonitrile; Pregnenolone-16alpha-carbonitrile; PCN

C22H31NO2 (341.2355)


   

5-Hydroxymethyl tolterodine

(R)-N,N-Diisopropyl-3-(2-hydroxy-5-hydroxymethylphenyl)-3-phenylpropanamine

C22H31NO2 (341.2355)


5-Hydroxymethyl tolterodine is only found in individuals that have used or taken tolterodine. 5-Hydroxymethyl tolterodine is a metabolite of tolterodine. 5-Hydroxymethyl tolterodine belongs to the family of Diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.

   

Pregnenolone carbonitrile

14-acetyl-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-ene-13-carbonitrile

C22H31NO2 (341.2355)


   

(8S,9S,10S,13S,14S,17S)-17-Acetyl-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-1-carbonitrile

(8S,9S,10S,13S,14S,17S)-17-Acetyl-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-1-carbonitrile

C22H31NO2 (341.2355)


   

Deoxycalyciphylline B

(1S,6R,7R,10R,15S,22R)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.01,6.07,15.010,14.019,22]docos-13-en-4-one

C22H31NO2 (341.2355)


   
   

Isodaphnilactone B

Isodaphnilactone B

C22H31NO2 (341.2355)


   

Malouetamide

Con-4-enine-3,18-dione

C22H31NO2 (341.2355)


   

Daphnilactone B

(-)-Daphnilactone B

C22H31NO2 (341.2355)


   
   

Spirafine III

Spirafine III

C22H31NO2 (341.2355)


   

19-methylaminoavarone|3-Methylaminoavarone

19-methylaminoavarone|3-Methylaminoavarone

C22H31NO2 (341.2355)


   

18-methylaminoavarone|2-Methylaminoavarone|3-methylaminoavarone

18-methylaminoavarone|2-Methylaminoavarone|3-methylaminoavarone

C22H31NO2 (341.2355)


   

18-methylaminoarenarone

18-methylaminoarenarone

C22H31NO2 (341.2355)


   

(E)-3,7-dimethylocta-2,6-dienyl 2-(3-methylbut-2-enylamino)benzoate|geranyl N-dimethylallylanthranilate

(E)-3,7-dimethylocta-2,6-dienyl 2-(3-methylbut-2-enylamino)benzoate|geranyl N-dimethylallylanthranilate

C22H31NO2 (341.2355)


   

dysidaminone I

dysidaminone I

C22H31NO2 (341.2355)


   

(2E,4E,10E)-N-isobutyl-11-(4-methoxyphenyl)undeca-2,4,10-trienamide|philippinamide

(2E,4E,10E)-N-isobutyl-11-(4-methoxyphenyl)undeca-2,4,10-trienamide|philippinamide

C22H31NO2 (341.2355)


   

(-)-bukittinggine

(-)-bukittinggine

C22H31NO2 (341.2355)


   

regholarrhenine|Regholarrhenine A

regholarrhenine|Regholarrhenine A

C22H31NO2 (341.2355)


   

hydroxy-3 oxo-9 seco-9,10 conatriene-1,3,5

hydroxy-3 oxo-9 seco-9,10 conatriene-1,3,5

C22H31NO2 (341.2355)


   

5-Hydroxymethyltolterodine

5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM)

C22H31NO2 (341.2355)


Desfesoterodine (PNU-200577) is a potent and selective muscarinic receptor (mAChR) antagonist with a KB and a pA2 of 0.84 nM and 9.14, respectively[1]. Desfesoterodine is a major pharmacologically active metabolite of Tolterodine (PNU-200583; HY-A0024) and Fesoterodine (HY-70053)[2][3]. Desfesoterodine improves cerebral infarction induced detrusor overactivity in rats[4].

   

(Rac)-5-Hydroxymethyl Tolterodine

(Rac)-5-Hydroxymethyl Tolterodine

C22H31NO2 (341.2355)


(Rac)-5-Hydroxymethyl Tolterodine ((Rac)-Desfesoterodine), an active metabolite of Tolterodine, is a mAChR antagonist (Ki values of 2.3 nM, 2 nM, 2.5 nM, 2.8 nM, and 2.9 nM for M1, M2, M3, M4, and M5 receptors, respectively). (Rac)-5-Hydroxymethyl Tolterodine can be used for overactive bladder research[1].

   

17-acetyl-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-16-carbonitrile

17-acetyl-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-16-carbonitrile

C22H31NO2 (341.2355)


   

Desfesoterodine

5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM)

C22H31NO2 (341.2355)


G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Desfesoterodine (PNU-200577) is a potent and selective muscarinic receptor (mAChR) antagonist with a KB and a pA2 of 0.84 nM and 9.14, respectively[1]. Desfesoterodine is a major pharmacologically active metabolite of Tolterodine (PNU-200583; HY-A0024) and Fesoterodine (HY-70053)[2][3]. Desfesoterodine improves cerebral infarction induced detrusor overactivity in rats[4].

   

CB2R/FAAH modulator-3

CB2R/FAAH modulator-3

C22H31NO2 (341.2355)


CB2R/FAAH modulator-3 (compound 27) is a dual targeting modulator that acts as a CB2R agonist and FAAH inhibitor. The Ki values for CB2R/FAAH modulator-3 are 20.1 and 67.6 nM for CB2R and CB1R, respectively, and the IC50 value for FAAH is 3.4 μM. CB2R/FAAH modulator-3 can be used in studies related to cancer, deleterious inflammatory cascades occurring in neurodegenerative diseases, and COVID-19 infection[1].

   

(1s,7s,10s,11r,15r,22r,23r)-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-18-en-4-one

(1s,7s,10s,11r,15r,22r,23r)-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-18-en-4-one

C22H31NO2 (341.2355)


   

(1s,2r,3r,5s,8r,9s,10r,13r,17r)-11-ethyl-8-hydroxy-13-methyl-4-methylidene-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-one

(1s,2r,3r,5s,8r,9s,10r,13r,17r)-11-ethyl-8-hydroxy-13-methyl-4-methylidene-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-one

C22H31NO2 (341.2355)


   

(5z,8z,11z)-n-[2-(4-hydroxyphenyl)ethyl]tetradeca-5,8,11-trienimidic acid

(5z,8z,11z)-n-[2-(4-hydroxyphenyl)ethyl]tetradeca-5,8,11-trienimidic acid

C22H31NO2 (341.2355)


   

(1s,6r,7s,10r,15r,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

(1s,6r,7s,10r,15r,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

C22H31NO2 (341.2355)


   

(1r,7r,10r,11s,15s,18s,23s)-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-21-en-4-one

(1r,7r,10r,11s,15s,18s,23s)-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-21-en-4-one

C22H31NO2 (341.2355)


   

11-ethyl-8-hydroxy-13-methyl-4-methylidene-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-one

11-ethyl-8-hydroxy-13-methyl-4-methylidene-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-one

C22H31NO2 (341.2355)


   

(2e,4e,10e)-11-(4-methoxyphenyl)-n-(2-methylpropyl)undeca-2,4,10-trienimidic acid

(2e,4e,10e)-11-(4-methoxyphenyl)-n-(2-methylpropyl)undeca-2,4,10-trienimidic acid

C22H31NO2 (341.2355)


   

(1s,6r,7s,10s,15r,18s,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

(1s,6r,7s,10s,15r,18s,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

C22H31NO2 (341.2355)


   

(1r,7r,10r,11s,15s,18r,23s)-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-21-en-4-one

(1r,7r,10r,11s,15s,18r,23s)-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-21-en-4-one

C22H31NO2 (341.2355)


   

n-[2-(4-hydroxyphenyl)ethyl]tetradeca-5,8,11-trienimidic acid

n-[2-(4-hydroxyphenyl)ethyl]tetradeca-5,8,11-trienimidic acid

C22H31NO2 (341.2355)


   

(1s,2s,3s,5r,8s,9s,10r,13r,17r)-11-ethyl-8-hydroxy-13-methyl-4-methylidene-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-one

(1s,2s,3s,5r,8s,9s,10r,13r,17r)-11-ethyl-8-hydroxy-13-methyl-4-methylidene-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-16-one

C22H31NO2 (341.2355)


   

(1s,6s,7s,10s,15r,18s,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

(1s,6s,7s,10s,15r,18s,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

C22H31NO2 (341.2355)


   

(1r,7r,10r,11r,15s,18r,23r)-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-21-en-4-one

(1r,7r,10r,11r,15s,18r,23r)-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-21-en-4-one

C22H31NO2 (341.2355)


   

2-{[(1r,2s,4as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-5-(methylamino)cyclohexa-2,5-diene-1,4-dione

2-{[(1r,2s,4as)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-5-(methylamino)cyclohexa-2,5-diene-1,4-dione

C22H31NO2 (341.2355)


   

(1s,2s,5s,6s,9r,11r,12s,13r)-11-hydroxy-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one

(1s,2s,5s,6s,9r,11r,12s,13r)-11-hydroxy-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one

C22H31NO2 (341.2355)


   

11-methyl-5-oxa-13-azaheptacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁴,¹⁸.0¹⁸,²²]tricosan-4-one

11-methyl-5-oxa-13-azaheptacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁴,¹⁸.0¹⁸,²²]tricosan-4-one

C22H31NO2 (341.2355)


   

(6r,7s,10s,15r,18s,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

(6r,7s,10s,15r,18s,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

C22H31NO2 (341.2355)


   

11-(4-methoxyphenyl)-n-(2-methylpropyl)undeca-2,4,10-trienimidic acid

11-(4-methoxyphenyl)-n-(2-methylpropyl)undeca-2,4,10-trienimidic acid

C22H31NO2 (341.2355)


   

(1r,7r,10r,14s,15s,22r)-11-methyl-5-oxa-13-azaheptacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁴,¹⁸.0¹⁸,²²]tricosan-4-one

(1r,7r,10r,14s,15s,22r)-11-methyl-5-oxa-13-azaheptacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁴,¹⁸.0¹⁸,²²]tricosan-4-one

C22H31NO2 (341.2355)


   

deoxyisocalyciphylline b

deoxyisocalyciphylline b

C22H31NO2 (341.2355)


   

(1r,7r,10r,11s,14r,15s,18r,22r,23s)-11-methyl-5-oxa-13-azaheptacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁴,¹⁸.0¹⁸,²²]tricosan-4-one

(1r,7r,10r,11s,14r,15s,18r,22r,23s)-11-methyl-5-oxa-13-azaheptacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁴,¹⁸.0¹⁸,²²]tricosan-4-one

C22H31NO2 (341.2355)


   

11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-21-en-4-one

11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-21-en-4-one

C22H31NO2 (341.2355)


   

11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-18-en-4-one

11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricos-18-en-4-one

C22H31NO2 (341.2355)


   

(1r,2s,5s,6s,9r,12s,13r)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-17-ene-8,16-dione

(1r,2s,5s,6s,9r,12s,13r)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-17-ene-8,16-dione

C22H31NO2 (341.2355)


   

6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

C22H31NO2 (341.2355)


   

(1s,6s,7r,10r,15r,18s,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

(1s,6s,7r,10r,15r,18s,19r,22s)-6,18-dimethyl-5-oxa-16-azahexacyclo[14.5.1.0¹,⁶.0⁷,¹⁵.0¹⁰,¹⁴.0¹⁹,²²]docos-13-en-4-one

C22H31NO2 (341.2355)


   

11-hydroxy-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one

11-hydroxy-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosa-14,17-dien-16-one

C22H31NO2 (341.2355)